Pre-Stroke Use of Beta-Blockers Does Not Lower Post-Stroke Infection Rate: An Exploratory Analysis of the Preventive Antibiotics in Stroke Study | Zendy

Willeke F. Westendorp | Zendy; JanDirk Vermeij | Zendy; Matthijs C. Brouwer | Zendy; Yvo B.W.E.M. Roos | Zendy; Paul J. Nederkoorn | Zendy; Diederik van de Beek | Zendy

Open Access

Pre-Stroke Use of Beta-Blockers Does Not Lower Post-Stroke Infection Rate: An Exploratory Analysis of the Preventive Antibiotics in Stroke Study

Author(s) -

Willeke F. Westendorp,

JanDirk Vermeij,

Matthijs C. Brouwer,

Yvo B.W.E.M. Roos,

Paul J. Nederkoorn,

Diederik van de Beek

Publication year - 2016

Publication title -

cerebrovascular diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.221

H-Index - 104

eISSN - 1421-9786

pISSN - 1015-9770

DOI - 10.1159/000450926

Subject(s) - medicine , stroke (engine) , prospective cohort study , ceftriaxone , antibiotics , clinical trial , gastroenterology , mechanical engineering , microbiology and biotechnology , engineering , biology

Stroke-associated infections occur frequently and are associated with unfavorable outcome. Previous cohort studies suggest a protective effect of beta-blockers (BBs) against infections. A sympathetic drive may increase immune suppression and infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research